Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dare Bioscience Inc (DARE)

Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dare Bioscience Inc 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 USA

www.darebioscience.com Employees: 23 P: 858-926-7655

Sector:

Medical

Description:

Dare Bioscience, Inc. is a healthcare company. It involved in the development and commercialization of products in women's reproductive health. Dare Bioscience, Inc., formerly known as Cerulean Pharma Inc., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 27,864
Enterprise Value, $K 12,164
Shares Outstanding, K 14,289
Float, K 13,603
% Float 95.20%
Short Interest, K 466
Short Float 3.26%
Days to Cover 1.25
Short Volume Ratio 0.43
% of Insider Shareholders 4.80%
% of Institutional Shareholders 6.70%
Annual Net Income, $ -4,050 K
Last Quarter Sales, $ -20 K
Last Quarter Net Income, $ -4,020 K
EBIT, $ -18,490 K
EBITDA, $ -18,450 K
3-Year Return -85.68%
5-Year Return -94.43%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 95.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 11/13/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -2.14
EPS Growth vs. Prev Qtr 37.78%
EPS Growth vs. Prev Year 49.09%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 07/01/24

DARE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 1.65
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -82.71%
Profit Margin % -40,500.00%
Debt/Equity 0.00
Price/Sales -2,786.40
Price/Cash Flow N/A
Price/Book 9.57
Book Value/Share -1.41
Interest Coverage -0.56
60-Month Beta 0.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar